Central Drugs Standard Control Organisation (CDSCO) has approved extension of self life of Covaxin up to 12 months, from date of manufacture. This approval is based on the availability of additional stability data, which was submitted to CDSCO: Bharat Biotech— Prasar Bharati News Services पą„.बą„.ą¤ą¤Ø.ą¤ą¤ø. (@PBNS_India) November 3, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


